| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock",
"Global Amendment No. 2, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P",
"Global Amendment No. 2, by and between Jaguar Health, Inc. and Uptown Capital, LLC",
"Global Amendment, by and between Jaguar Health, Inc. and Streeterville Capital, LLC",
"Global Amendment No. 2, by and between Jaguar Health, Inc. and Streeterville Capital, LLC",
"Form of Warrant",
"Exchange Agreement, by and between Jaguar Health, Inc. and Uptown Capital, LLC" |
|
| 08/14/2023 |
4
| Jayasuriya Anula (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 1,718 shares
@ $0
Granted 68,568 shares
@ $0
Granted 1,718 options to buy
@ $0 |
|
| 08/14/2023 |
4
| Siegel Jonathan B. (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 68,568 shares
@ $0 |
|
| 08/14/2023 |
4
| MICEK JOHN (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 68,568 shares
@ $0 |
|
| 08/14/2023 |
4
| BOCHNOWSKI JAMES J (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 76,613 shares
@ $0 |
|
| 08/14/2023 |
4
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 204,192 shares
@ $0 |
|
| 08/14/2023 |
4
| Wolin Jonathan S. (Chief of Staff, CCO & GC) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 196,628 shares
@ $0 |
|
| 08/14/2023 |
4
| Lizak Carol R. (CFO) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 142,088 shares
@ $0 |
|
| 08/14/2023 |
4
| King Steven R. (see remarks) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 159,168 shares
@ $0 |
|
| 08/14/2023 |
4
| CONTE LISA A (CEO and President) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Granted 383,605 shares
@ $0 |
|
| 08/14/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/13/2023 |
SC 13G
| Fife John M. reports a |
| 07/07/2023 |
8-K
| Quarterly results |
| 07/03/2023 |
8-K
| Quarterly results |
| 05/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/19/2023 |
4
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 870 restricted stock units
@ $0 |
|
| 05/19/2023 |
4/A
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 133 shares
@ $0
Granted 133 restricted stock units
@ $0 |
|
| 05/19/2023 |
4/A
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 10,000 shares
@ $0
Granted 10,000 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Siegel Jonathan B. (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 1,145 options to buy
@ $0 |
|
| 05/19/2023 |
4
| MICEK JOHN (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 1,145 options to buy
@ $0 |
|
| 05/19/2023 |
4
| BOCHNOWSKI JAMES J (Director) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 1,280 options to buy
@ $0 |
|
| 05/19/2023 |
4
| Wolin Jonathan S. (Chief of Staff, CCO & GC) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 871 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Lizak Carol R. (CFO) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 431 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| King Steven R. (Chief of Sustainable Supply) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 611 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| CONTE LISA A (CEO and President) has filed a Form 4 on Jaguar Health, Inc.|
Txns:
| Exercised 2,694 restricted stock units
@ $0 |
|
| 05/19/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/16/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 05/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/15/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/12/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/11/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
|